QSS
CNST

Quantitative Systematic Strategies’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Quantitative Systematic Strategies’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,746
Closed -$597K – 812
2020
Q4 		$597K Sell
20,746
-698
-3% -$17.6K 0.08% 354
2020
Q3 		$434K Buy
21,444
+1,834
+9% +$44.8K 0.08% 354
2020
Q2 		$589K Buy
19,610
+5,222
+36% +$188K 0.12% 270
2020
Q1 		$452K Sell
14,388
-283
-2% -$9.84K 0.37% 97
2019
Q4 		$691K Buy
+14,671
New +$424K 0.1% 281

Other funds holding CNST

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Quantitative Systematic Strategies's CNST Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q1 2021, closing a stake of 20,746 shares — an estimated $597K sold.

Quantitative Systematic Strategies first reported a position in CNST in Q4 2019 and held it in 5 quarters. The position peaked at $691K in Q4 2019. 131 funds tracked by Wall St. Rank hold CNST as of Q1 2021.

  • Quantitative Systematic Strategies reported no remaining Constellation Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 20,746 Constellation Pharmaceuticals, Inc. shares in Q1 2021, an estimated $597K.
  • Quantitative Systematic Strategies first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Constellation Pharmaceuticals, Inc. position peaked at $691K in Q4 2019.
  • 131 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.